Status:

UNKNOWN

Fluorescence Spectroscopy for Gut Permeability Assessment

Lead Sponsor:

Imperial College London

Conditions:

Development and Validation of Gut Permeability Sensor

Permeability; Increased

Eligibility:

All Genders

18+ years

Brief Summary

This research aims to develop portable devices - known as fluorescence spectrometers - to monitor the leakage of fluorescent dyes out of the gut into the blood stream. These devices will measure the l...

Detailed Description

"Leaky gut" - or, increased permeability of the intestine - involves the leakage of certain intestinal constituents (e.g. endotoxins or even bacteria) from the gut into the rest of the body. This cond...

Eligibility Criteria

Inclusion

  • Ability to give informed consent
  • Aged 18 years or above
  • No evidence of prior adverse reactions to fluorescein, ICG, dextran or PEG
  • No evidence of prior adverse reactions to iodine (for ICG experiments only)
  • For healthy volunteers: healthy with no active GI/liver disease (or other condition in which increased gut permeability is expected, e.g. HIV) and no antibiotics taken within the previous four weeks.
  • For cases: exhibiting symptoms of GI, liver or other diseases (e.g. HIV) in which increased intestinal permeability is expected.
  • For ophthalmology patients recruited in Stage 1: healthy (i.e. as described above for healthy volunteers) and prescribed to have an ophthalmic angiography with an intravenous injection of either fluorescein or ICG.

Exclusion

  • Unable to give informed consent
  • Aged \<18 years
  • Previous adverse reaction to fluorescein, ICG, dextran or PEG
  • Known allergy to iodine (for ICG experiments only)
  • Pregnancy (in Stage 1 this will be at the discretion of the patient's ophthalmologist)
  • Breastfeeding (in Stage 1 this will be at the discretion of the ophthalmologist)

Key Trial Info

Start Date :

March 29 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 30 2021

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03434639

Start Date

March 29 2019

End Date

September 30 2021

Last Update

February 12 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IMPERIAL COLLEGE Healthcare Trust

London, United Kingdom, W2 1NY